Additionally, the expression levels of FYN and KDM4A were found to be correlated with poor prognosis in a previously reported breast cancer cohort (Hatzis et al., 2011), highlighting the potential of targeting these two genes as therapeutic targets for TNBC (Figure 4C). This evidence concerns the gene FYN and breast carcinoma.